scholarly article | Q13442814 |
P50 | author | Emad A. Rakha | Q55098175 |
Ian Ellis | Q55300055 | ||
Srinivasan Madhusudan | Q56435835 | ||
Patrick J Tighe | Q56448978 | ||
Ola H Negm | Q56942400 | ||
Andrew Green | Q55098173 | ||
P2093 | author name string | Alaa T Alshareeda | |
Christopher Nolan | |||
Nada Albarakati | |||
Rebeka Sultana | |||
Ahmed Benhasouna | |||
P2860 | cites work | The mechanism of double-strand DNA break repair by the nonhomologous DNA end-joining pathway | Q22065419 |
The role of double-strand break repair — insights from human genetics | Q22122018 | ||
DNA double-strand breaks: signaling, repair and the cancer connection | Q28204231 | ||
RAD51 up-regulation bypasses BRCA1 function and is a common feature of BRCA1-deficient breast tumors | Q28253705 | ||
The mechanism of human nonhomologous DNA end joining | Q28257187 | ||
Association of BRCA1 with Rad51 in mitotic and meiotic cells | Q28302118 | ||
Breast cancer risk and the DNA double-strand break end-joining capacity of nonhomologous end-joining genes are affected by BRCA1. | Q31095234 | ||
DNA ligase IV-deficient cells are more resistant to ionizing radiation in the absence of Ku70: Implications for DNA double-strand break repair | Q33947027 | ||
Role of non-homologous end joining (NHEJ) in maintaining genomic integrity | Q34544982 | ||
DNA-dependent protein kinase activity is absent in xrs-6 cells: implications for site-specific recombination and DNA double-strand break repair | Q34868235 | ||
Involvement of the Ku autoantigen in the cellular response to DNA double-strand breaks | Q35652566 | ||
A means to a DNA end: the many roles of Ku. | Q35762470 | ||
Somatic loss of BRCA1 and p53 in mice induces mammary tumors with features of human BRCA1-mutated basal-like breast cancer | Q35901185 | ||
Basal-like breast cancer: a critical review | Q37167032 | ||
Absence of p350 subunit of DNA-activated protein kinase from a radiosensitive human cell line | Q41368190 | ||
Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer | Q42450903 | ||
Triple-negative breast cancer: distinguishing between basal and nonbasal subtypes | Q42451354 | ||
BRCA1 dysfunction in sporadic basal-like breast cancer | Q42502209 | ||
Expression of BRCA1 protein in breast cancer and its prognostic significance | Q42526565 | ||
Expression of DNA double-strand break repair proteins ATM and BRCA1 predicts survival in colorectal cancer | Q44283662 | ||
The expression pattern of Ku correlates with tumor radiosensitivity and disease free survival in patients with rectal carcinoma | Q44414853 | ||
Ku70 predicts response and primary tumor recurrence after therapy in locally advanced head and neck cancer. | Q46546357 | ||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | DNA damage | Q5205747 |
P304 | page(s) | 301-310 | |
P577 | publication date | 2013-04-28 | |
P1433 | published in | Breast Cancer Research and Treatment | Q326085 |
P1476 | title | Clinicopathological significance of KU70/KU80, a key DNA damage repair protein in breast cancer | |
P478 | volume | 139 |
Q39003101 | 7B7: a novel antibody directed against the Ku70/Ku80 heterodimer blocks invasion in pancreatic and lung cancer cells |
Q37266446 | Abnormal DNA-PKcs and Ku 70/80 expression may promote malignant pathological processes in gastric carcinoma |
Q64099911 | Apoptosis Induction byHistone Deacetylase Inhibitors in Cancer Cells: Role of Ku70 |
Q90398064 | Association Of GSTM1, GSTT1 And GSTP1 Polymorphisms With Breast Cancer Among Jordanian Women |
Q35678658 | Checkpoint kinase1 (CHK1) is an important biomarker in breast cancer having a role in chemotherapy response |
Q42496885 | Clinical and biological significance of RAD51 expression in breast cancer: a key DNA damage response protein |
Q38900933 | Clinical and biological significance of glucocorticoid receptor (GR) expression in breast cancer |
Q55261738 | Clinical values of Ku80 upregulation in superficial esophageal squamous cell carcinoma. |
Q89967133 | Combination Therapy With Charged Particles and Molecular Targeting: A Promising Avenue to Overcome Radioresistance |
Q64258395 | Comparative genomics sheds light on the predatory lifestyle of accipitrids and owls |
Q35131267 | DNA damage response markers are differentially expressed in BRCA-mutated breast cancers |
Q36792475 | Differences of Variable Number Tandem Repeats in XRCC5 Promoter Are Associated with Increased or Decreased Risk of Breast Cancer in BRCA Gene Mutation Carriers |
Q92533625 | Genetic association of XRCC5 gene polymorphisms with breast cancer among Jordanian women |
Q30239810 | Identification of Biomarkers for Breast Cancer Using Databases |
Q36086823 | KPNA2 is a nuclear export protein that contributes to aberrant localisation of key proteins and poor prognosis of breast cancer |
Q42016675 | Overexpression of Ku80 correlates with aggressive clinicopathological features and adverse prognosis in esophageal squamous cell carcinoma |
Q53598546 | Overexpression of Ku80 suggests poor prognosis of locally advanced esophageal squamous cell carcinoma patients. |
Q41715562 | Postoperative Radiotherapy Improves Survival in Stage pT2N0M0 Esophageal Squamous Cell Carcinoma with High Risk of Poor Prognosis |
Q50437809 | Prognostic and biological significance of peroxisome proliferator-activated receptor-gamma in luminal breast cancer. |
Q50457473 | Prognostic and biological significance of proliferation and HER2 expression in the luminal class of breast cancer. |
Q41252181 | Prognostic significance of Ku80 in pT2N0M0 esophageal squamous cell carcinoma after Ivor-Lewis esophagectomy |
Q38226307 | Radioresistance in head and neck squamous cell carcinoma: Biological bases and therapeutic implications |
Q39019431 | SUMOylation proteins in breast cancer |
Q35740074 | Selective Targeting to Glioma with Nucleic Acid Aptamers |
Q55019644 | The Incidence of Other Primary Cancers in Patients with Cutaneous Lymphoma. |
Q38690281 | The Role of the Core Non-Homologous End Joining Factors in Carcinogenesis and Cancer |
Q45784223 | Transcriptional signature of lymphoblastoid cell lines of BRCA1, BRCA2 and non-BRCA1/2 high risk breast cancer families |
Search more.